Loading…
Essential role of mitochondrial Stat3 in p38 MAPK mediated apoptosis under oxidative stress
Stat3 is an oncogene, frequently associated with malignant transformation. A body of evidence implicates that phospho-Stat3 contributes to its nucleic translocation, while phospho-Stat3 leads to the accumulation in mitochondria. Both are of importance for tumor cell proliferation. In comparison to w...
Saved in:
Published in: | Scientific reports 2017-11, Vol.7 (1), p.15388 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Stat3 is an oncogene, frequently associated with malignant transformation. A body of evidence implicates that phospho-Stat3
contributes to its nucleic translocation, while phospho-Stat3
leads to the accumulation in mitochondria. Both are of importance for tumor cell proliferation. In comparison to well-characterized signaling pathways interplaying with Stat3
, little is known about Stat3
. In this work, we studied the influence of Stat3 deficiency on the viability of cells exposed to H
O
or hypoxia using siRNA and CRISPR/Cas9 genome-editing. We found dysregulation of mitochondrial activity, which was associated with excessive ROS formation and reduced mitochondrial membrane potential, and observed a synergistic effect for oxidative stress-mediated apoptosis in Stat3-KD cells or cells carrying Stat3
, but not Stat3
, suggesting the importance of functional mitochondrial Stat3 in this context. We also found that ROS-mediated activation of ASK1/p38
was involved and adding antioxidants, p38
inhibitor, or genetic repression of ASK1 could easily rescue the cellular damage. Our finding reveals a new role of mitochondrial Stat3 in preventing ASK1/p38
-mediated apoptosis, wich further support the notion that selective inhibition mitochondrial Stat3 could provide a primsing target for chemotherapy. |
---|---|
ISSN: | 2045-2322 2045-2322 |
DOI: | 10.1038/s41598-017-15342-4 |